Ranbaxy Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Established
1996-08-30
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Minocycline 100mg Tablets
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
28
Registration Number
NCT00776542
Locations
🇺🇸

AII pharma, Chapell Hill, North Carolina, United States

Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Glimepiride 1mg Tablets
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776490
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: loratadine 10 mg orally disintegrating
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
80
Registration Number
NCT00776282

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Cetirizine Hydrochloride 10 mg tablet
First Posted Date
2008-10-20
Last Posted Date
2010-03-02
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776022
Locations
🇺🇸

Bioanalytical Systems, Inc, Baltimore, Maryland, United States

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Fenofibrate 160 mg tablets
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
24
Registration Number
NCT00775359
Locations
🇺🇸

MDS Pharma Services, Phoenix, Arizona, United States

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Cetirizine Hydrochloride 10 mg tablet
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776139
Locations
🇺🇸

Bioanalytical Systems, Inc., Baltimore, Maryland, United States

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Clorazepate Dipotassium 15mg Tablets
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00775996
Locations
🇺🇸

MDS Pharma Services, Lincoln, Nebraska, United States

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Clarithromycin 250mg/5mL
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00775372
Locations
🇮🇳

Ranbaxy Research Laboratories, Gurgaon, Haryana, India

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Carvedilol 12.5 mg tablets
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00775619

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Carvedilol 12.5 mg tablets
First Posted Date
2008-10-20
Last Posted Date
2008-10-20
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00776113
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy